Although SIADH is more common, CSWS is a well-recognized cause of hyponatremia in patients with subarachnoid hemorrhage
This ensures weight loss goals are achieved safely, while also planning for long-term health maintenance
The FDA's April 2026 proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List signals a regulatory environment that will demand more from online sellers, and platforms that support compliance workflows will have a structural advantage
VANQUISH-1 is fully enrolled with approximately 4,500 patients, and the Phase 3 oral program is expected to begin in Q3 2026, with maintenance dosing results also due that quarter
Discover the top 7 energy peptides backed by clinical research
The results show that after 12 weeks, the number of EPCs significantly increased in the MeDE group, with a greater increase compared to the MeD group